Behavioral and molecular characterization of cell-type specific populations governing 42 fear learning and behavior is a promising avenue for the rational identification of potential 43 therapeutics for fear-related disorders. Examining cell-type specific changes in neuronal 44 translation following fear learning allows for targeted pharmacological intervention during fear 45 extinction learning, mirroring possible treatment strategies in humans. Here we identify the 46 central amygdala (CeA) Drd2-expressing population as a novel fear-supporting neuronal 47 population that is molecularly distinct from other, previously identified, fear-supporting CeA 48 populations. Sequencing of actively translating transcripts of Drd2 neurons using translating 49 ribosome affinity purification (TRAP) technology identifies mRNAs that are differentially 50 regulated following fear learning. Differentially expressed transcripts with potentially targetable 51 gene products include Npy5r, Rxrg, Adora2a, Sst5r, Fgf3, Erbb4, Fkbp14, Dlk1, and Ssh3. Direct 52 pharmacological manipulation of NPY5R, RXR, and ADORA2A confirms the importance of 53 this cell population and these cell-type specific receptors in fear behavior. Furthermore, these 54 findings validate the use of functionally identified specific cell populations to predict novel 55 pharmacological targets for the modulation of emotional learning. 56 Introduction 57 The amygdala is a mediator of the acquisition and expression of learned associative 58 fear 1,2 . Composed primarily of GABAergic medium spiny neurons, the central amygdala (CeA) 59 is intimately involved in controlling the expression of fear related behaviors 3,4 . Each of the 60 CeA's three main sub-nuclei (lateral capsular (CeC), lateral (CeL), and medial (CeM)) play 61 distinct roles in specific behaviors and contain molecularly distinct sub-populations that have 62 further behavioral specializations 5-10 . In the present set of experiments, we utilized Pavlovian 63 fear conditioning, a paradigm used extensively for studying associative fear memories formed by 64 the pairings of conditioned stimuli (CS; e.g. a tone) and unconditioned stimuli (US; e.g. a mild 65 foot shock) 11-13 . Learned fearful associations may be 'extinguished' with additional unreinforced 66 presentations of the CS alone, a process that closely resembles the clinical practice of exposure 67 therapy used in treating individuals with PTSD. A promising area of treatment in PTSD includes 68 the pharmacological enhancement of exposure-based therapies 14 . The aim of this study is to 69 harness cell-type specific molecular techniques in order to identify more specific and effective 70 pharmacotherapies for the treatment of fear-related disorders. 71 Foundational research as well as more recent analyses highlight the striatum-like nature 72 of the central amygdala 15 . Striatal dopamine receptor 1 (Drd1) populations (direct pathway 73 neurons) promote movement, while dopamine receptor 2 (Drd2) populations (indirect pathway 74 neurons) inhibit movement 16,17 . Within the posterior CeA, it has been reported that corticotropin 75 releasing factor (Crh), tachykinin 2 (Tac2), somatostatin (Sst), and neurotensin (Nts) expressing 76 populations are contained within the larger Drd1 expressing neuron population that promote 77 directed motivational behaviors under certain conditions 18,19 . Conversely, within the anterior 78 CeC, the protein kinase C-δ (Prkcd) and calcitonin receptor-like (Calcrl) co-expressing 79 population has been reported to be a sub-population of Drd2 neurons mediating defensive 80 behaviors or inhibiting motivated behaviors 19,20 . Given its potential role in fear behavior, the 81 CeA Drd2 expressing population is a high value target for translational investigation.
fear conditioned (5 CS/US tone-shock pairings with 0.5 sec, 0.65 mA foot shock US) or exposed 196 to the tone CS in the chamber in the absence of any US. Fear conditioned animals exhibited 197 expected increases in freezing responses to the CS (Supplemental Figure 4A ). Animals were then 198 sacrificed 2 h following behavior, micropunches centered over the CeA were collected, and 199 TRAP was performed to obtain isolated mRNA from Drd2 neurons ( Figure 3E ). High quality 200 RNA was retrieved from the TRAP protocol (RIN=8.5-10). To verify the specificity of RNA Sequencing of RNA collected from Drd2 neuron ribosomes revealed genes dynamically 211 regulated following fear conditioning, many of which have been previously reported to be 212 involved in fear and anxiety-like behaviors ( Figure 3F ). False discovery rate (FDR) adjusted p-213 values were calculated and FDR of 5% and fold-change of 2^0 .5 cut-offs were set(Full list of 214 differentially expressed genes is in Supplemental Table 1 ). Using, the Mouse Gene Atlas dataset, 215 initial analysis using Enrichr confirms amygdala specificity of pull-down and gene change 216 (Supplemental Table 2) 43 . Further enrichment analysis using Jensen Compartments dataset 217 6 confirms neuronal specificity of pull down and gene change (Supplemental Table 3 ). Consistent 218 with activity dependent gene changes, MetaCore Gene Ontology Processes identifies neuronal 219 developmental and adenylate cyclase related processes as highly significantly recruited by fear 220 conditioning ( Figure 4A ). MetaCore Gene Ontology Diseases identifies Schizophrenia and 221 nervous system diseases as gene categories most related to gene changes in Drd2 neurons 222 ( Figure 4B ). Interestingly, GSEA identified gene group differences in the entire RNA-seq dataset 223 as most concordantly similar, but in the opposite direction to two gene data sets identified in Figure 6 ) 44,45 . This is informative for interpreting the enrichment of our top FDR-significant 226 genes with Schizophrenia disease set by MetaCore. Weighted network analysis was completed to 227 examine differential expression of Drd2 genes in the context of human PTSD. Using
228
GeneMANIA Cytoscape, differentially expressed transcripts were mapped into a self-organizing 229 weighted network, where all of the genes were interlinked at multiple levels (co-expression, 230 physical interactions, common pathway) ( Figure 4C ) 46, 47 . Over-all gene network analysis reveals 231 that differentially regulated genes are primarily co-expressed and are part of common ontologies 232 without belonging to a single dominant pathway. To identify potential targets for 233 pharmacological manipulation, differentially expressed genes were examined for the availability 234 of agonists or antagonists using MetaCore Drugs for Drug targets tool (Supplemental Table 4 ).
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Finally, potential drug targets were examined in the literature for being high quality, blood-brain 236 barrier penetrant, agonists or antagonists. Using this identification approach, inclusive of our a 237 priori interest in Adora2a among other potential Drd2-neuron specific genes (above studies),
238
Npy5r, and Rxrg were selected for further pharmacological examination 48-51 . Additional markers 239 found to be modulated with fear learning that may be of further interest also include Sst5r, Fgf3, To examine the effect of ADORA2A antagonism on fear extinction three cohorts of mice 258 were fear conditioned(5 CS/US, 0.65 mA foot shock)( Figure 5B were again injected with istradefylline (3 mg/kg) (group V/I) or vehicle (groups I/V and V/V).
263
Injection of istradefylline but not vehicle prior to fear extinction (15 CS, Extinction 1) greatly 264 decreased freezing during extinction training when drug was on-board ( Figure 5D ). Twenty-four 265 hours later, following drug clearance, mice that had previously been injected with istradefylline 266 prior to fear extinction, but not those injected following it, expressed significantly less freezing 267 during a second extinction session (15CS, Extinction 2). These data suggest that blockade of 268 ADORA2A during fear extinction, but not during extinction consolidation, is sufficient to 269 enhance fear extinction learning. CeL. This is remarkable because the posterior CeL contains the densest Crh, Nts, Sst, Prkcd, and 353 Tac2, populations that were reported to correspond with Drd1a neurons in this area. This 354 discrepancy may again be due to our more strict criteria for positively expressing cells. 355 Overall, the presented behavioral data are remarkably consistent. Manipulation of the 356 Drd2 neuronal population either through Gs-DREADD, or the inhibition of ADORA2A (G αs ) or 357 NPY5R (G αi ), drives fear expression in directions consistent with this being a fear supporting 358 population. ADORA2a is known to be co-expressed with D2R and these receptors have been 359 shown to have opposing actions, suggesting that both receptors may be viable candidates for 360 modulation of a single sub-population 61,62 . An important consideration is that drugs were 361 administered systemically, thus making it impossible to claim that effects were mediated 362 exclusively through receptors found in the CeA. However, as the goal of this line of research is 363 to identify potentially clinically relevant targets for enhancement of therapy, it is advantageous to 364 test candidates as they would be used in the clinic, that is, systemically and prior to exposure 
RNA-Seq Library Preparation 478
Libraries were generated from 1ng of Total RNA using the SMARTer HV kit (Clonetech), Analysis of RNA sequencing data 485 RNA sequencing data was analyzed using Tuxedo DESeq analysis software. Differential 486 expression between HC and FC groups were obtained and used for further analysis. Using the q 487 value of less than .05 as a cut-off, only highly significant returns were used for further analysis.
488
To ensure that genes had a large enough difference in expression to warrant pharmacological 489 manipulation, only those with differences in expression greater than 2 .5 or ~141% were 490 considered. Sections were taken at a width of 16 µm. Procedure was completed to manufacturers 531 specifications.
533
Image acquisition 534 Images were acquired with the experimenter blinded to the probes used. 16-bit images of 535 staining were acquired on a Leica SP8 confocal microscope using a 10x, 20x, or 40x objective.
536
Images for 1A-F and 4B and E were acquired using a Zeiss Imager a1 with a 2x or 4x objective.
537
Within a sample, images used for quantification were acquired with identical settings for laser 538 13 power, detector gain, and amplifier offset. Images were acquired as a z-stack of 10 steps of .5 µm 539 each. Max intensity projections were then created and analyzed. A. Two groups of animals (FC1 and FC 30) were fear conditioned (5 CS/US, .65 mA 721 US). B. Twenty-four hours three groups of animals were exposed to extinction context. FC1 was 722 exposed to a single CS in extinction context. Percent freezing indicates freezing during tone 723 during CS 1 and freezing during the corresponding time when tone was played for other groups 724 for CS 2-30, freezing during CS 1 was significantly greater than control (unpaired t-Test 725 F(1,12)=5.929, p < .0001). HC 30 group did not receive fear conditioning, but was exposed to 726 30 CS's in extinction context. FC 30 was exposed to 30 CS's in extinction context and expressed 727 more freezing than HC 30 group (Each bin examined by students t-test p < .05). C. Four groups 728 were sacrificed 2 hours following behavior and qPCR performed on amygdala punches. FC30 729 group had significantly increased Drd2expression compared to all other groups. Supplemental Table 3 . Jensen COMPARTMENTS analysis. 743 Jensen COMPARTMENTS analysis data set, using sequence based prediction methods confirms 744 neuronal specificity of pull-down and gene change.
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Supplemental Table 4 . Drug-Gene analysis of differentially expressed genes. 747 Metacore 'Drug for Drug database' identifies drugs that target protein products of differentially 748 expressed genes .   749  750  751  752  753  754  755  756  757  758  759  760  761  762  763  764  765  766  767  768  769  770  771 
